BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of nitric oxide
,
Lovastatin
,
rs2230926
,
BRCA1
,
Allergy to pollen
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
prostaglandins
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Prostaglandin-modulated umbilical cord blood hematopoietic stem cells
Explore Curated Studies Results
Literature
Most Relevant Literature
A concise and scalable chemoenzymatic synthesis of prostaglandins.
EP4 Receptor Conformation Sensor Suited for Ligand Screening and Imaging of Extracellular Prostaglan…
Roles of prostaglandins in immunosuppression.
Prostaglandins as local regulators of ovarian physiology in ruminants.
Prostaglandin Metabolites Analysis in Urine by LC-MS/MS.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy
The Use of Prostaglandin E1 in Head and Neck Microsurgery
Prostaglandin E1 in Outpatients With Intermittent Claudication
Effects of Prostaglandin E1 Treatment on Pyloric Wall in Newborns
Prostaglandins Before Caserean Section
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ